BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension

Clinical trial NCT03235232 · COMPLETED

Trial details

NCT number: NCT03235232
Sponsor: EMS
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ocular Hypertension Primary Open-angle Glaucoma

Start date: 2021-02-01
Primary completion: 2023-07-31
Enrollment: 406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.